The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis

Nature Medicine

Volumn 10, Issue 2, 2004, Pages 182-186

  Khanna, Chand ^a   Wan, Xiaolin ^a   Bose, Seuli ^a   Cassaday, Ryan ^a   Olomu, Osarenoma ^a   Mendoza, Arnulfo ^a   Yeung, Choh ^a   Gorlick, Richard ^b   Hewitt, Stephen M ^a   Helman, Lee J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EZRIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; AKT1 PROTEIN, HUMAN; CYTOSKELETON PROTEIN; ONCOPROTEIN; PHOSPHOPROTEIN; PROTEIN SERINE THREONINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOG; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; MOUSE; NONHUMAN; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; ANIMAL; CELL MEMBRANE; CHILD; CYTOSKELETON; HUMAN; LUNG TUMOR; METABOLISM; METASTASIS; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; SURVIVAL RATE; TUMOR CELL LINE;

ANIMALIA; CANIS FAMILIARIS;

ANIMALS; CELL LINE, TUMOR; CELL MEMBRANE; CHILD; CYTOSKELETAL PROTEINS; CYTOSKELETON; DOGS; HUMANS; LUNG NEOPLASMS; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM METASTASIS; OSTEOSARCOMA; PHOSPHOPROTEINS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; SURVIVAL RATE;

EID: 11144357298     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm982     Document Type: Article

References (27)

1. Khanna, C. et al. Metastasis-associated differences in gene expression in a murine model of osteosarcoma. Cancer Res. 61, 3750-3759 (2001).
2. Algrain, M., Turunen, O., Vaheri, A., Louvard, D. & Arpin, M. Ezrin contains cytoskeleton and membrane binding domains accounting for its proposed role as a membrane-cytoskeletal linker. J. Cell Biol. 120, 129-139 (1993).
3. Bretscher, A., Edwards, K. & Fehon, R.G. ERM proteins and merlin: integrators at the cell cortex. Nat. Rev. Mol. Cell Biol. 3, 586-599 (2002).
4. Nguyen, R., Reczek, D. & Bretscher, A. Hierarchy of merlin and ezrin N and C-terminal domain interactions in homo and heterotypic associations and their relationship to binding of scaffolding proteins EBP50 and E3KARP. J. Biol. Chem. 276, 7621-7629 (2001).
5. Martin, T.A., Harrison, G., Mansel, R.E. & Jiang, W.G. The role of the CD44/ezrin complex in cancer metastasis. Crit. Rev. Oncol. Hematol. 46, 165-186 (2003).
6. Ohtani, K. et al. Ezrin, a membrane-cytoskeletal linking protein, is highly expressed in atypical endometrial hyperplasia and uterine endometrioid adenocarcinoma. Cancer Lett. 179, 79-86 (2002).
7. Makitie, T., Carpen, O., Vaheri, A. & Kivela, T. Ezrin as a prognostic indicator and its relationship to tumor characteristics in uveal malignant melanoma. Invest. Ophthalmol. Vis. Sci. 42, 2442-2449 (2001).
8. Gautreau, A., Louvard, D. & Arpin, M. Morphogenic effects of ezrin require a phosphorylation-induced transition from oligomers to monomers at the plasma membrane. J. Cell Biol. 150, 193-203 (2000).
9. Chambers, A.F. et al. Critical steps in hematogenous metastasis: an overview. Surg. Oncol. Clin. N. Am. 10, 243-255 (2001).
10. Clark, E.A., Golub, T.R., Lander, E.S. & Hynes, R.O. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406, 532-535 (2000).
11. Chambers, A.F., Naumov, G.N., Vantyghem, S.A. & Tuck, A.B. Molecular biology of breast cancer metastasis. Clinical implications of experimental studies on metastatic inefficiency. Breast Cancer Res. 2, 400-407 (2000).
12. Wong, C.W. et al. Intravascular location of breast cancer cells after spontaneous metastasis to the lung. Am. J. Pathol. 161, 749-753 (2002).
13. Wong, C.W. et al. Apoptosis: an early event in metastatic inefficiency. Cancer Res. 61, 333-338 (2001).
14. Luzzi, K.J. et al. Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am. J. Pathol. 153, 865-873 (1998).
15. Gautreau, A., Poullet, P., Louvard, D. & Arpin, M. Ezrin, a plasma membrane-microfilament linker, signals cell survival through the phosphatidylinositol 3-kinase/Akt pathway. Proc. Natl. Acad. Sci. USA 96, 7300-7305 (1999).
16. Ward, Y. et al. Signal pathways which promote invasion and metastasis: critical and distinct contributions of extracellular signal-regulated kinase and Ral-specific guanine exchange factor pathways. Mol. Cell Biol. 21, 5958-5969 (2001).
17. Vail, D.M. & MacEwen, E.G. Spontaneously occurring tumors of companion animals as models for human cancer. Cancer Invest. 18, 781-792 (2000).
18. Withrow, S.J., Powers, B.E., Straw, R.C. & Wilkins, R.M. Comparative aspects of osteosarcoma. Dog versus man. Clin. Orthop. 270, 159-168 (1991).
19. Khanna, C. et al. A randomized controlled trial of octreotide pamoate long-acting release and carboplatin versus carboplatin alone in dogs with naturally occurring osteosarcoma: evaluation of insulin-like growth factor suppression and chemotherapy. Clin. Cancer Res. 8, 2406-2412 (2002).
20. Crepaldi, T., Gautreau, A., Comoglio, P.M., Louvard, D. & Arpin, M. Ezrin is an effector of hepatocyte growth factor-mediated migration and morphogenesis in epithelial cells. J. Cell Biol. 138, 423-434 (1997).
21. Hiscox, S. & Jiang, W.G. Ezrin regulates cell-cell and cell-matrix adhesion, a possible role with E-cadherin/β-catenin. J. Cell Sci. 112, 3081-3090 (1999).
22. Yu, Y. et al. Expression profiling identifies the cytoskeletal organizer Ezrin and the developmental homeoprotein Six1 as key metastatic regulators. Nat. Med. 10, 48-54 (2004)
23. Reddy, K.B., Nabha, S.M. & Atanaskova, N. Role of MAP kinase in tumor progression and invasion. Cancer Metastasis Rev. 4, 395-403 (2003).
24. Ramaswamy, S., Ross, K.N., Lander, E.S. & Golub, T.R. A molecular signature of metastasis in primary solid tumors. Nat. Genet. 33, 49-54 (2003).
25. Khanna, C. et al. An orthotopic model of murine osteosarcoma with clonally related variants differing in pulmonary metastatic potential. Clin. Exp. Metastasis 18, 261-271 (2000).26.
26. Lamb, R. et al. Essential functions of ezrin in maintenance of cell shape and lamellipodial extension in normal and transformed fibroblasts. Curr. Biol. 7, 682-688 (1997).
27. Wan, X. & Helman, L.J. Effect of insulin-like growth factor II on protecting myoblast cells against cisplatin-induced apoptosis through p70 S6 kinase pathway. Neoplasia 4, 400-408 (2002).